SB
IGMS

Samsara BioCapital’s IGM Biosciences IGMS Stock Holding History

Samsara BioCapital’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-154,664
Closed -$1.06M – 43
2024
Q2 		$1.06M Hold
154,664
– – 0.22% 31
2024
Q1 		$1.49M Hold
154,664
– – 0.23% 30
2023
Q4 		$1.29M Hold
154,664
– – 0.2% 31
2023
Q3 		$1.29M Hold
154,664
– – 0.4% 30
2023
Q2 		$1.43M Hold
154,664
– – 0.25% 33
2023
Q1 		$2.13M Hold
154,664
– – 0.44% 33
2022
Q4 		$2.63M Hold
154,664
– – 0.57% 28
2022
Q3 		$3.52M Hold
154,664
– – 0.82% 27
2022
Q2 		$2.79M Hold
154,664
– – 0.74% 29
2022
Q1 		$4.13M Buy
+154,664
New +$2.88M 1.04% 26

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Samsara BioCapital's IGMS Position: Q3 2024 in Review

Samsara BioCapital sold out of IGM Biosciences (IGMS) in Q3 2024, closing a stake of 154,664 shares — an estimated $1.06M sold.

Samsara BioCapital first reported a position in IGMS in Q1 2022 and held it in 10 quarters. The position peaked at $4.13M in Q1 2022. 72 funds tracked by Wall St. Rank hold IGMS as of Q3 2024.

  • Samsara BioCapital reported no remaining IGM Biosciences position as of Q3 2024 after selling out during the quarter.
  • Samsara BioCapital sold 154,664 IGM Biosciences shares in Q3 2024, an estimated $1.06M.
  • Samsara BioCapital first reported a position in IGM Biosciences in Q1 2022 and held it in 10 quarters.
  • Samsara BioCapital's IGM Biosciences position peaked at $4.13M in Q1 2022.
  • 72 funds tracked by Wall St. Rank held IGM Biosciences as of Q3 2024.

Based on Samsara BioCapital's 13F filing for Q3 2024, filed 14 Nov 2024.